This medicine may increase the risk of a birth defect called cleft lip and palate in a newborn
Results indicate that combination therapies yield significant therapeutic benefits for managing thyroid disorders, suggesting that plant-based medicines may offer multi-target effects with gentler efficacy profiles
BPC-157 is commonly discussed for chronic pain related to joint stress, connective tissue injuries, and inflammation
Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects
It is better to err on the safe side and thus the broken line is placed 25% below the solid line which defines possible toxicity
These effects could directly explain why we see variations in redness and inflammation in KP subtypes Rubra and Alba
